18F-FDG-PET/MRI in preoperative staging of oesophageal and gastroesophageal junctional cancer

Shapiro, 2015, Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial, Lancet Oncol, 16, 1090, 10.1016/S1470-2045(15)00040-6 Klevebro, 2017, Current trends in multimodality treatment of oesophageal and gastroesophageal junction cancer, Surg Oncol, 26, 290, 10.1016/j.suronc.2017.06.002 DaVee, 2017, Is endoscopic ultrasound examination necessary in the management of oesophageal cancer?, World J Gastroenterol, 23, 751, 10.3748/wjg.v23.i5.751 Lee, 2014, Clinical implication of PET/MR imaging in preoperative oesophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT, J Nucl Med, 55, 1242, 10.2967/jnumed.114.138974 Heusch, 2013, Standardized uptake values for [(1)(8)F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI, Eur J Radiol, 82, 870, 10.1016/j.ejrad.2013.01.008 Partovi, 2014, Qualitative and quantitative performance of (1)(8)F-FDG-PET/MRI versus (1)(8)F-FDG-PET/CT in patients with head and neck cancer, AJNR Am J Neuroradiol, 35, 1970, 10.3174/ajnr.A3993 Catalano, 2013, Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients—a hypothesis-generating exploratory study, Radiology, 269, 857, 10.1148/radiol.13131306 Sobin, 2010 Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 Venkatesh, 2011, Normal magnetic resonance imaging of the thorax, Magn Reson Clin N Am, 19, 489, 10.1016/j.mric.2011.05.014 Riddell, 2007, High-resolution MRI in evaluation of the surgical anatomy of the oesophagus and posterior mediastinum, AJR Am J Roentgenol, 188, W37, 10.2214/AJR.05.1795 Riddell, 2007, The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation, Eur Radiol, 17, 391, 10.1007/s00330-006-0363-6 Takashima, 1991, Carcinoma of the oesophagus: CT vs MR imaging in determining resectability, AJR Am J Roentgenol, 156, 297, 10.2214/ajr.156.2.1898802 Hong, 2014, New TNM staging system for oesophageal cancer: what chest radiologists need to know, RadioGraphics, 34, 1722, 10.1148/rg.346130079 Napier, 2014, Oesophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment techniques, World J Gastrointest Oncol, 6, 112, 10.4251/wjgo.v6.i5.112 Noordman, 2018, Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial, BMC Cancer, 18, 142, 10.1186/s12885-018-4034-1 Dijon van Rossum, 2015, Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in oesophageal cancer, Radiother Oncol, 115, 163, 10.1016/j.radonc.2015.04.027 Heethuis, 2016, Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy, Radiother Oncol, 120, 128, 10.1016/j.radonc.2016.05.009 Liu, 2017, Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer, Clin Cancer Res, 23, 7253, 10.1158/1078-0432.CCR-17-1038 Kinahan, 2010, PET/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy, Semin Ultrasound CT MRI, 31, 496, 10.1053/j.sult.2010.10.001 Zhu, 2012, Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis, Br J Radiol, 85, e694, 10.1259/bjr/29946900 Kurland, 2016, Multicenter clinical trials using 18F-FDG PET to measure early response to oncologic therapy: effects of injection-to-acquisition time variability on required sample size, J Nucl Med, 57, 226, 10.2967/jnumed.115.162289 Beaulieu, 2003, SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences, J Nucl Med, 44, 1044 Lodge, 1999, A PET study of 18FDG uptake in soft tissue masses, Eur J Nucl Med, 26, 22, 10.1007/s002590050355 Nahmias, 2008, Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumours, J Nucl Med, 49, 1804, 10.2967/jnumed.108.054239 Wangerin, 2015, Effect of (18)F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancer, Tomography (Ann Arbor, Mich), 1, 53, 10.18383/j.tom.2015.00151